Press Releases

Welcome to the Investing News Network's press release section, where you can stay informed with past and present announcements from our clients. Explore the latest stock news from mining, technology and life science companies and gain an investing edge by staying up to date with today's press releases.
Filters
Clear All Filters
Filter ✕

Date Range

Sector

BriaCell Therapeutics (BCT:CC)

BriaCell Therapeutics: Redefining Oncology with Personalized Cancer Immunotherapy

biotech investing
Lexaria Bioscience (LEXX)

Lexaria Bioscience Releases Second Episode of Investor Video Series

biotech investing
Lexaria Bioscience (LEXX)

Lexaria Updates Progress on Human Study #7

biotech investing
Lexaria Bioscience (LEXX)

Lexaria Bioscience Launches Ongoing Investor Video Series to Expand Shareholder Communications

biotech investing
Lexaria Bioscience (LEXX)

Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended

biotech investing
Lexaria Bioscience (LEXX)

Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs

biotech investing
Lexaria Bioscience (LEXX)

Lexaria Bioscience:  Drug Delivery Platform Innovator with Multiple Mainstream Applications

biotech investing
Lexaria Bioscience (LEXX)

Lexaria Expects Oral GLP-1 Pills to Generate Billions in New Industry Sales

biotech investing
Seegnal (SEGN:CA)

Seegnal Inc. Receives Gold Mark from the Standards Institution of Israel, Advancing Commercialization Readiness

biotech investing
Lexaria Bioscience (LEXX)

Lexaria's New Animal Study Aims to Expand Valuable Intellectual Property

biotech investing
Lexaria Bioscience (LEXX)

Lexaria's New Animal Study Aims to Expand Valuable Intellectual Property

biotech investing
Lexaria Bioscience (LEXX)

Lexaria Applauds Eli Lilly's Foundayo Drug Approval

biotech investing
Lexaria Bioscience (LEXX)

Lexaria Applauds Eli Lilly's Foundayo Drug Approval

biotech investing
Solvonis Therapeutics (None)

SVN-114 selected as the lead candidate for PTSD discovery programme

pharmaceutical investing
Cardiol Therapeutics (CRDL:CC)

Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference

biotech investing
Cardiol Therapeutics (CRDL:CC)

Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure

biotech investing
Seegnal (SEGN:CA)

Seegnal Expands Deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a Leading Israeli Public Medical Center and Global Referral Center

biotech investing
Solvonis Therapeutics (None)

Expansion of SVN-015 into Depression Following Positive Preclinical Data

pharmaceutical investing
Cardiol Therapeutics (CRDL:CC)

Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million

biotech investing
Cardiol Therapeutics (CRDL:CC)

Cardiol Therapeutics Announces Bought Deal Financing for Gross Proceeds of $13.5 Million

biotech investing

Latest News

More News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES